cabecera

Condroprotección

Espacio dirigido a profesionales de la salud, dedicado a la prevención, tratamiento e investigación de la artrosis

Multimedia

EULAR 2014

June 11-14, Paris, France

TREATING PATIENTS NOT DISEASES:
The new challenge of personalised healthcare


Symposium BIOIBERICA
Thursday June 12, 08:15h-09:45h. Room Passy
Program:

Welcome and introduction
Ingrid Möller, MD, PhD (Barcelona, Spain)

Osteoarthritis: a case for personalizad health care?
Virginia Byers kraus, MD, PhD (Durham, North Carolina, US)


Genetic polymorphisms can predict knee OA progression. Results from the Arthrotest® multicenter association study
Ingrid Möller, MD, PhD (Barcelona, Spain)


Development and validation of a genetic model for fracture prediction in post-menopausal women. Results from European cohort study
Serge Ferrari, MD (Geneva, Switzerland)


Biochemical markers to monitor the effects of drugs in knee OA patients
Yves Henrotin, PhD (Liege, Belgium)


Question and answer session


Concluding Remarks
Virginia Byers Kraus, MD, PhD (Durham, North Carolina, US)
Ingrid Möller, MD, PhD (Barcelona, Spain)


An international, double-blind, randomized trial versus celecoxib

Symposium BIOIBERICA
Friday, June 13, 08:15h-09:45h. Room Passy
 
Program:

Welcome and introduction
Francisco J. Blanco, MD, PhD (A Coruña, Spain)


MOVES rationale, protocol and study design
Pascal Richette, MD, MSc, PhD (Paris, France)


Effects of combined chondroitin sulfate and glucosamine vs celecoxib in patients with moderate-to-severe knee OA pain
Jean-Pierre Pelletier, MD (Montreal, Quebec, Canada)


Safety considerations from MOVES trial
Marc C. Hochberg, MD, MPH (Baltimore, MD, United States)


Impact of meniscal extrusion on the progression of knee OA structural changes: Data from the Osteoarthritis Initiative Progression Cohort
Johanne Martel-Pelletier, PhD (Montreal, Quebec, Canada)


Question and Answer Session


Concluding Remarks
Philip Conaghan, MB BS, PhD, FRACP, FRCP (Leeds, UK)
Francisco J. Blanco, MD, PhD (A Coruña, Spain)


Más información aquí



* Esta web no está destinada a reportar efectos adversos de los productos de Bioibérica. Si desea reportar efectos adversos, contacte con el departamento de Farmacovigilancia
Copyright © 2018, Bioiberica, S.A. Todos los derechos reservados.